Translational Research in Pediatric and Obstetric Pharmacology (R21)

archived

Purpose. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages research grant applications to conduct studies to improve existing drug saftey and efficacy, and to develop new drugs for pediatric and obstetric populations. The overall goals of this FOA are to support: (1) pharmacological studies addressing the special differences of drug actions and responses among children at various developmental stages, between children and adults, and between pregnant and non-pregnant women; (2) development of new drug targeting children and pregnant women; (3) multidisciplinary collaborations between basic and physician scientists to improve the use of therapeutics in obstetrics and pediatrics. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PAR-09-155, that encourages applications under the R01 grant mechanism and PAR-09-154 that encourages applications under the R03 grant mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received.

High